Recent studies have shown that loss of FBXW7 function causes therapeutic resistance through the accumulation of several oncoproteins associated with tumor progression and therapeutic resistance, including cyclin E, c-Myc, c-Jun, Notch and MCL1 [27,28,29,30,31]. Here, MCL1 is linked to neoplasm.